Skip to main content

Advertisement

Log in

Reduced Esophageal Contractility Is Associated with Dysplasia Progression in Barrett’s Esophagus: A Multicenter Cohort Study

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

The incidence of Barrett’s esophagus (BE) and esophageal adenocarcinoma (EAC) continues to rise, and risk stratification of patients with BE is needed. Impaired esophageal motility is associated with gastroesophageal reflux disease; however, whether esophageal dysmotility is a risk factor for dysplasia progression in BE is incompletely understood. This study aimed to characterize esophageal motility patterns in patients with BE and identify physiologic factors associated with dysplasia progression in BE.

Methods

This multicenter retrospective study assessed data from adult patients with histologically confirmed BE who underwent high-resolution esophageal manometry from 1/2014 to 1/2018 at four tertiary care centers. Longitudinal data were collected when available among patients with non-dysplastic BE (NDBE) and separated as: no dysplastic progression or positive dysplastic progression. Multivariable logistic regression assessed for independent predictors of dysplasia progression.

Results

Among 193 patients, histology at index endoscopy identified 152 (79%) NDBE, 23 (12%) low-grade dysplasia, 14 (7%) high-grade dysplasia, and 4 (2%) EAC. Ninety-eight (51%) had abnormal esophageal motor function on manometry. Longitudinal data were available for 84 of 152 patients with initial NDBE. Twelve (14%) exhibited dysplastic progression to low-grade (6) or high-grade (6) dysplasia. Mean esophageal distal contractile integral was lower for patients that progressed [455 mmHg s cm (SD 515)] compared with patients who did not progress [987 mmHg s cm (SD 953); aOR 1.21 (95% CI 1.01, 1.44)].

Conclusion

In this retrospective study of 193 BE patients, the majority exhibited abnormal esophageal motor function. Reduced esophageal contractility was independently associated with dysplastic progression in BE. Characterizing esophageal physiology in BE may help to risk stratify patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

BE:

Barrett’s esophagus

EAC:

Esophageal adenocarcinoma

NDBE:

Non-dysplastic Barrett’s esophagus

LGD:

Low-grade dysplasia

HGD:

High-grade dysplasia

PPI:

Proton pump inhibitor

GERD:

Gastroesophageal reflux disease

BMI:

Body mass index

IRP:

Integrated relaxation pressure

DCI:

Distal contractile integral

EGJ-CI:

Esophagogastric junction contractile integral

PSPWi:

Post-reflux swallow peristaltic wave index

aOR:

Adjusted odds ratio

CI:

Confidence interval

SD:

Standard deviation

References

  1. Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG. Barrett’s esophagus: development of dysplasia and adenocarcinoma. Gastroenterology. 1989;96:1249–1256.

    Article  CAS  Google Scholar 

  2. Kestens C, Offerhaus GJ, van Baal JW, Siersema PD. Patients with Barrett’s esophagus and persistent low-grade dysplasia have an increased risk for high-grade dysplasia and cancer. Clin Gastroenterol Hepatol. 2016;14:956.e1–962.e1.

    Article  Google Scholar 

  3. Thrift AP, Whiteman DC. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol. 2012;23:3155–3162.

    Article  CAS  Google Scholar 

  4. Desai M, Lieberman DA, Kennedy KF, et al. Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett’s esophagus over the past 2 decades: data from a multicenter U.S. consortium. Gastrointest Endosc. 2018;89:257–263.

    Article  Google Scholar 

  5. Codipilly DC, Chandar AK, Singh S, et al. The effect of endoscopic surveillance in patients with Barrett’s esophagus: a systematic review and meta-analysis. Gastroenterology. 2018;154:2068e5–2086e5.

    Article  Google Scholar 

  6. Krishnamoorthi R, Singh S, Ragunathan K, et al. Factors associated with progression of Barrett’s esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16:1046e8–1055e8.

    Article  Google Scholar 

  7. Thrift AP, Garcia JM, El-Serag HB. A multibiomarker risk score helps predict risk for Barrett’s esophagus. Clin Gastroenterol Hepatol. 2014;12:1267–1271.

    Article  Google Scholar 

  8. Rubenstein JH, Morgenstern H, Appelman H, et al. Prediction of Barrett’s esophagus among men. Am J Gastroenterol. 2013;108:353–362.

    Article  Google Scholar 

  9. Oberg S, DeMeester TR, Peters JH, et al. The extent of Barrett’s esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. J Thorac Cardiovasc Surg. 1999;117:572–580.

    Article  CAS  Google Scholar 

  10. Helman L, Biccas BN, Lemme EM, Novais P, Fittipaldi V. Esophageal manometry findings and degree of acid exposure in short and long Barrett’s esophagus. Arq Gastroenterol. 2012;49:64–68.

    Article  Google Scholar 

  11. Blevins CH, Iyer PG, Vela MF, Katzka DA. The esophageal epithelial barrier in health and disease. Clin Gastroenterol Hepatol. 2018;16:608–617.

    Article  CAS  Google Scholar 

  12. Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27:160–174.

    Article  CAS  Google Scholar 

  13. Wani S, Gaddam S. Editorial: Best practices in surveillance of Barrett’s esophagus. Am J Gastroenterol. 2017;112:1056–1060.

    Article  Google Scholar 

  14. Parasa S, Vennalaganti S, Gaddam S, et al. Development and validation of a model to determine risk of progression of Barrett’s esophagus to neoplasia. Gastroenterology. 2018;154:1282e2–1289e2.

    Article  Google Scholar 

  15. Sanagapalli S, Emmanuel A, Leong R, et al. Impaired motility in Barrett’s esophagus: a study using high-resolution manometry with physiologic challenge. Neurogastroenterol Motil. 2018. https://doi.org/10.1111/nmo.13330.

  16. Bazin C, Benezech A, Alessandrini M, Grimaud JC, Vitton V. Esophageal motor disorders are a strong and independent associated factor of Barrett’s esophagus. J Neurogastroenterol Motil. 2018;24:216–225.

    Article  Google Scholar 

  17. Farre R, van Malenstein H, De Vos R, et al. Short exposure of oesophageal mucosa to bile acids, both in acidic and weakly acidic conditions, can impair mucosal integrity and provoke dilated intercellular spaces. Gut. 2008;57:1366–1374.

    Article  CAS  Google Scholar 

  18. Xiao Y, Kahrilas PJ, Kwasny MJ, et al. High-resolution manometry correlates of ineffective esophageal motility. Am J Gastroenterol. 2012;107:1647–1654.

    Article  Google Scholar 

  19. Kahrilas PJ. Esophageal motor activity and acid clearance. Gastroenterol Clin North Am. 1990;19:537–550.

    CAS  PubMed  Google Scholar 

  20. Frazzoni M, de Bortoli N, Frazzoni L, et al. The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring. Neurogastroenterol Motil. 2017;29.

  21. Patel A, Wang D, Sainani N, Sayuk GS, Gyawali CP. Distal mean nocturnal baseline impedance on pH-impedance monitoring predicts reflux burden and symptomatic outcome in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2016;44:890–898.

    Article  CAS  Google Scholar 

  22. Wang D, Patel A, Mello M, Shriver A, Gyawali CP. Esophagogastric junction contractile integral (EGJ-CI) quantifies changes in EGJ barrier function with surgical intervention. Neurogastroenterol Motil. 2016;28:639–646.

    Article  CAS  Google Scholar 

Download references

Funding

None related to this manuscript.

Author information

Authors and Affiliations

Authors

Contributions

RY, SW, JT, FQ, SE, SB, JP, SK, PG, PMK contributed to study concept and design; RY and SW involved in study oversight; RY, SW, ZV, JT, FQ, SE, SB, JP, SK, PG, NJS, PMK participated in acquisition of data; RY, SW, AK took part in analysis and interpretation of data; RY, SW, AK, JT, FQ, SE, SB, JP, SK, PG, PMK involved in drafting of manuscript; RY, SW, AK, JT, FQ, SE, SB, JP, SK, PG, NJS, PMK took part in critical revision of the manuscript for important intellectual content; RY, SW, AK, JT, FQ, SE, SB, JP, SK, PG, NJS, PMK participated in finalization of manuscript.

Corresponding author

Correspondence to Rena Yadlapati.

Ethics declarations

Conflict of interest

JEP: Consultant for Crospon, Ironwood, Torax, Astra Zeneca, Takeda, Impleo, Medtronic, Sandhill.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 14 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yadlapati, R., Triggs, J., Quader, F. et al. Reduced Esophageal Contractility Is Associated with Dysplasia Progression in Barrett’s Esophagus: A Multicenter Cohort Study. Dig Dis Sci 65, 3631–3638 (2020). https://doi.org/10.1007/s10620-020-06098-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-020-06098-5

Keywords

Navigation